"Application of Bioactive Molecules in the Treatment and Management of Type-1 Diabetic Disease"

The following is a summary of bioactive chemicals that have been described by researchersbased on experimental or clinical antidiabetic data and used in traditional medical systems.Diabetes mellitus is one of the most common non-communicable diseases in the world. Athorough investigation was carried out to gather information on ayurveda, homoeopathic,unani, yoga, and other therapies. It is a metabolic dysfunction disease of the endocrine systemthat affects over 10% of the world’s population, with the number of those affected growingby the day. The scientific and family names, plant parts and test model employed, degree ofhypoglycemic activity, and active chemical compounds are all available in the profiles. Allbioactive treatments have been demonstrated to be beneficial in the treatment of diabeticcomplications and in lowering blood glucose levels in diabetics with DBT-1. Natural oraltreatment also significantly lowered glucose levels and insulin requirements in diabetic-1patients, but more clinical research is needed to determine the exact mechanism.

[1]  A. Shukla.  DIABETES MELLITUS-A REPORT ON ANTIDIABETIC MEDICINAL PLANTS AND THEIR POTENT BIOACTIVE MOLECULES , 2021, Journal of Medical pharmaceutical and allied sciences.

[2]  J. Nevalainen,et al.  Association of diabetes type and chronic diabetes complications with early exit from the labour force: register-based study of people with diabetes in Finland , 2021, Diabetologia.

[3]  R. Tiwari,et al.  Plant metabolites and their role in health benefits: A brief review , 2020, Advance Pharmaceutical Journal.

[4]  B. Loos,et al.  Evaluating All Potential Oral Complications of Diabetes Mellitus , 2019, Front. Endocrinol..

[5]  S. Russell,et al.  Type 1 Diabetes - A Clinical Perspective. , 2017, Point of care.

[6]  S. Lodhi,et al.  Hypoglycemic and hypolipidemic effects of ethanolic and aqueous extracts from Ziziphus oenoplia (L) Mill on alloxan-induced diabetic rats , 2017 .

[7]  P. Tiwari,et al.  Molecular Cloning and Biochemical Characterization of a Recombinant Sterol 3-O-Glucosyltransferase from Gymnema sylvestre R.Br. Catalyzing Biosynthesis of Steryl Glucosides , 2014, BioMed research international.

[8]  Zhen Gu,et al.  Emerging micro- and nanotechnology based synthetic approaches for insulin delivery. , 2014, Chemical Society reviews.

[9]  Marc M Cohen,et al.  Yoga and hypertension: a systematic review. , 2014, Alternative therapies in health and medicine.

[10]  D. Coustan,et al.  Gestational diabetes mellitus. , 2013, Clinical chemistry.

[11]  L. Dimeglio,et al.  Type 1 Diabetes , 2019, Epidemiology of Diabetes.

[12]  A. Goldfine,et al.  Statins and risk of new-onset diabetes mellitus. , 2012, Circulation.

[13]  C. Cannon,et al.  The controversies of statin therapy: weighing the evidence. , 2012, Journal of the American College of Cardiology.

[14]  Y-H Chen,et al.  Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[15]  S. Ali,et al.  Effects of yoga - pranayama practices on metabolic parameters and anthropometry in type 2 diabetes , 2011 .

[16]  J. McKnight,et al.  Statins should be routinely prescribed in all adults with diabetes , 2010 .

[17]  R. Coppari,et al.  Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice , 2010, Proceedings of the National Academy of Sciences.

[18]  F. Djouad,et al.  Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications , 2010, Stem Cell Research & Therapy.

[19]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[20]  Y. Hori.  Insulin-producing cells derived from stem/progenitor cells: therapeutic implications for diabetes mellitus , 2009, Medical Molecular Morphology.

[21]  F. Kim,et al.  Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. , 2009, Endocrinology.

[22]  Robin Goland,et al.  Generation of pluripotent stem cells from patients with type 1 diabetes , 2009, Proceedings of the National Academy of Sciences.

[23]  R. Campbell,et al.  Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. , 2009, Journal of the American Pharmacists Association : JAPhA.

[24]  M. Foss,et al.  Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. , 2009, JAMA.

[25]  L. Moretta,et al.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.

[26]  K. Gamber,et al.  Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. , 2009, Cell metabolism.

[27]  T. N. Qureshi,et al.  Antidiabetic Activity of Some Herbal Plants in Streptozotocin Induced Diabetic Albino Rats , 2009 .

[28]  S. Malik,et al.  Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment. , 2009, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[29]  B. P. Das,et al.  Effect of Ocimum sanctum, ascorbic acid, and verapamil on macrophage function and oxidative stress in mice exposed to cocaine , 2009, Indian journal of pharmacology.

[30]  B. Gower,et al.  Catamenial Diabetic Ketoacidosis and Catamenial Hyperglycemia: Case Report and Review of the Literature , 2008, The American journal of the medical sciences.

[31]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[32]  N. Wulffraat,et al.  Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005 , 2007, Arthritis research & therapy.

[33]  Radha Boddepalli,et al.  A database of 389 medicinal plants for diabetes , 2006, Bioinformation.

[34]  P. Butler,et al.  The Potential for Stem Cell Therapy in Diabetes , 2006, Pediatric Research.

[35]  E. Kang,et al.  Antidiabetic agents from medicinal plants. , 2006, Current medicinal chemistry.

[36]  M. Schwartz,et al.  Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. , 2005, Cell metabolism.

[37]  H. Jun,et al.  Approaches for the cure of type 1 diabetes by cellular and gene therapy. , 2005, Current gene therapy.

[38]  Y. S. Rao,et al.  Mucoadhesive microspheres for controlled drug delivery. , 2004, Biological & pharmaceutical bulletin.

[39]  B. Burkhardt,et al.  In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. , 2004, Diabetes.

[40]  M. Fujimiya,et al.  In vivo gene therapy for diabetes mellitus. , 2003, Trends in molecular medicine.

[41]  M. Zern,et al.  Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Joshi.  Metabolic syndrome--emerging clusters of the Indian phenotype. , 2003, The Journal of the Association of Physicians of India.

[43]  O. Pedersen,et al.  MULTIFACTORIAL INTERVENTION AND CARDIOVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETES , 2003 .

[44]  N. Morral,et al.  Novel targets and therapeutic strategies for type 2 diabetes , 2003, Trends in Endocrinology & Metabolism.

[45]  M. Fujimiya,et al.  NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice , 2003, Nature Medicine.

[46]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[47]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[48]  J. Altomonte,et al.  Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes. , 2002, Human gene therapy.

[49]  T. Clackson,et al.  Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer , 2002, Gene Therapy.

[50]  S. Yadav,et al.  Medicinal plants of India with anti-diabetic potential. , 2002, Journal of ethnopharmacology.

[51]  R. Chakrabarti,et al.  Diabetes and insulin resistance associated disorders: Disease and the therapy , 2002 .

[52]  D. Ludwig,et al.  The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. , 2002, JAMA.

[53]  M. Franz,et al.  The evidence for the effectiveness of medical nutrition therapy in diabetes management. , 2002, Diabetes care.

[54]  R. Perfetti,et al.  Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. , 2002, European journal of endocrinology.

[55]  H. Jun,et al.  Recent advances in insulin gene therapy for type 1 diabetes. , 2002, Trends in molecular medicine.

[56]  D. Moller,et al.  New drug targets for type 2 diabetes and the metabolic syndrome , 2001, Nature.

[57]  Hengjiang Dong,et al.  Hepatic insulin production for type 1 diabetes , 2001, Trends in Endocrinology & Metabolism.

[58]  P. Halban,et al.  Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? , 2001, Diabetes.

[59]  C. Newgard,et al.  Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1. , 2000, Diabetes.

[60]  Hyun Chul Lee,et al.  Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.

[61]  J. Mckinlay,et al.  US public health and the 21st century: diabetes mellitus , 2000, The Lancet.

[62]  I. Barshack,et al.  Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia , 2000, Nature Medicine.

[63]  P Anderson,et al.  Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen. , 2000, The Journal of clinical investigation.

[64]  C. Newgard,et al.  Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. , 1999, Diabetes.

[65]  C. Saper,et al.  From Lesions to Leptin Hypothalamic Control of Food Intake and Body Weight , 1999, Neuron.

[66]  J. Pessin,et al.  Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice. , 1998, American journal of physiology. Endocrinology and metabolism.

[67]  P. Muzzin,et al.  Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. , 1997, Molecular endocrinology.

[68]  D. K. Majumdar,et al.  Evaluation of antiinflammatory activity of fatty acids of Ocimum sanctum fixed oil. , 1997, Indian journal of experimental biology.

[69]  Shambaditya Goswami,et al.  Preliminary assessment of Calotropis gigantea leaves extract for in vitro antidiabetic activity , 2019, Advance Pharmaceutical Journal.

[70]  S. Inzucchi.  Oral Antihyperglycemic Therapy for Type 2 Diabetes , 2017 .

[71]  Betty C. Jung,et al.  [Gestational Diabetes]. , 2016, Journal of midwifery & women's health.

[72]  A. Shukla,et al.  HEPATOPROTECTIVE ACTIVITY OF LEAVES EXTRACTS OF CARISSA CARANDAS LINN , 2014 .

[73]  V. Mohan,et al.  Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve study. , 2013, The Journal of the Association of Physicians of India.

[74]  M. Charde,et al.  HERBAL REMEDIES AS ANTIOXIDANTS: AN OVERVIEW , 2012 .

[75]  Jun Wu,et al.  Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. , 2008, Cell transplantation.

[76]  Mohamed H. Sayegh,et al.  Immunomodulation by Mesenchymal Stem Cells , 2008, Diabetes.

[77]  A. Ziyyat,et al.  MEDICINAL PLANTS WITH POTENTIAL ANTIDIABETIC ACTIVITY - A REVIEW OF TEN YEARS OF HERBAL MEDICINE RESEARCH (1990-2000) , 2006 .

[78]  T. Ludwig,et al.  The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. , 2005, Cell metabolism.

[79]  T. Otonkoski,et al.  STEM CELL IN THE TREATMENT OF DIABETES , 2005 .

[80]  K. Chien,et al.  Development. ES cells to the rescue. , 2004, Science.

[81]  A. Vaidya,et al.  Ayurveda and natural products drug discovery , 2004 .

[82]  M. Hussain,et al.  In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. , 2003, The Journal of clinical investigation.

[83]  S. Bhadada,et al.  Newer Oral Antidiabetic Agents , 2003 .

[84]  S. Dahanukar,et al.  Immunotherapeutic modification of experimental infections by Indian medicinal plants , 1989 .

[85]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[86]  C. Bhandari,et al.  Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source. , 1977, Upsala journal of medical sciences.